Characterization of Potential Adverse Outcome Pathways Related to Metabolic Outcomes and Exposure to Per- and Polyfluoroalkyl Substances Using Artificial Intelligence
Open Access
Abstract
Human exposure to per- and polyfluoroalkyl substances (PFAS) has been associated with numerous adverse health effects, depending on various factors such as the conditions of exposure (dose/concentration, duration, route of exposure, etc.) and characteristics associated with the exposed target (e.g., age, sex, ethnicity, health status, and genetic predisposition). The biological mechanisms by which PFAS might affect systems are largely unknown. To support the risk assessment process, AOP-helpFinder, a new artificial intelligence tool, was used to rapidly and systematically explore all available published information in the PubMed database. The aim was to identify existing associations between PFAS and metabolic health outcomes that may be relevant to support building adverse outcome pathways (AOPs). The collected information was manually organized to investigate linkages between PFAS exposures and metabolic health outcomes, including dyslipidemia, hypertension, insulin resistance, and obesity. Links between PFAS exposure and events from the existing metabolic-related AOPs were also retrieved. In conclusion, by analyzing dispersed information from the literature, we could identify some associations between PFAS exposure and components of existing AOPs. Additionally, we identified some linkages between PFAS exposure and metabolic outcomes for which only sparse information is available or which are not yet present in the AOP-wiki database that could be addressed in future research.Keywords
Funding Information
- HBM4EU project (733032 HBM4EU, 825712)
- European Union’s Horizon 2020 Research and Innovation Programme OBERON (733032 HBM4EU, 825712)
This publication has 59 references indexed in Scilit:
- Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humansEnvironment International, 2013
- Positive Association Between Perfluoroalkyl Chemicals and Hyperuricemia in ChildrenAmerican Journal of Epidemiology, 2013
- Evaluation of cellular response to perfluorooctane sulfonate in human umbilical vein endothelial cellsToxicology in Vitro, 2012
- Perfluoroalkyl chemicals and elevated serum uric acid in US adultsClinical Epidemiology, 2011
- Perfluoroalkyl Chemicals and Chronic Kidney Disease in US AdultsAmerican Journal of Epidemiology, 2011
- Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Uric Acid among Adults with Elevated Community Exposure to PFOAEnvironmental Health Perspectives, 2010
- Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessmentEnvironmental Toxicology and Chemistry, 2009
- Harmonizing the Metabolic SyndromeCirculation, 2009
- A comprehensive definition for metabolic syndromeDisease Models & Mechanisms, 2009
- Perfluorodecanoic acid, a peroxisome proliferator, activates phospholipase C, inhibits CTP:phosphocholine cytidylyltransferase, and elevates diacylglycerol in rat liverToxicology Letters, 1996